tradingkey.logo

Bioharvest Sciences Inc

BHST
查看詳細走勢圖
4.790USD
+0.140+3.01%
收盤 02/06, 16:00美東報價延遲15分鐘
93.96M總市值
虧損本益比TTM

Bioharvest Sciences Inc

4.790
+0.140+3.01%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+3.01%

5天

-2.44%

1月

-8.59%

6月

-39.37%

今年開始到現在

-7.71%

1年

-15.64%

查看詳細走勢圖

TradingKey Bioharvest Sciences Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

Bioharvest Sciences Inc當前公司基本面數據相對健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在食品與煙草行業排名45/96位。機構持股佔比較高,近一月多位分析師給出公司評級為買入。最高目標價為13.67。中期看,股價處於下降通道。近一個月,市場表現一般,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Bioharvest Sciences Inc評分

相關信息

行業排名
45 / 96
全市場排名
236 / 4521
所屬行業
食品與煙草

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Bioharvest Sciences Inc亮點

亮點風險
BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
業績高增長
公司營業收入穩步增長,連續3年增長358.13%
業績增長期
公司處於發展階段,最新年度總收入25.19M美元
估值高估
公司最新PE估值-7.04,處於3年歷史高位
機構加倉
最新機構持股270.74K股,環比增加4.18%

分析師目標

基於 3 分析師
買入
評級
13.667
目標均價
+193.91%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Bioharvest Sciences Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Bioharvest Sciences Inc簡介

BioHarvest Sciences Inc. is a botanical synthesis company. The Company leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
公司代碼BHST
公司Bioharvest Sciences Inc
CEOSobel (Ilan)
網址https://bioharvest.com/about/
KeyAI